Héctor Perez-Montoyo

3PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 07, 2023
RANK is a poor prognosis marker and a therapeutic target in ER-negative postmenopausal breast cancer.

Marina Ciscar, Eva M Trinidad, Gema Perez-Chacon

|Sep 19, 2022
The ERK5/NF-κB signaling pathway targets endometrial cancer proliferation and survival.

Nora Diéguez-Martínez, Sergio Espinosa-Gil, Guillermo Yoldi

|Mar 16, 2022
ABTL0812 enhances antitumor effect of paclitaxel and reverts chemoresistance in triple-negative breast cancer models.

Emma Polonio-Alcalá, Sònia Solé-Sánchez, Pau Muñoz-Guardiola

Pageof 1